Other Clinical Trial - Effects of Paxil CR on Neural Circuits in

Status Completed

Clinical Trial Summary

Posttraumatic stress disorder (PTSD) is a major public health problem in this country. It is estimated that at least one out of every seven women in our society have been the victim of childhood sexual abuse at least once before their 18th birthday. Previous studies have shown that stress is associated with damage to neurons of the hippocampus, a brain area involved in learning and memory. Also, imaging studies of brain function are consistent with dysfunction of the medial prefrontal cortex during presentation of traumatic cues. We have previously shown that serotonin reuptake inhibitor medications (paroxetine; Paxil) can change memory function and hippocampal structure in PTSD. We now propose to perform a placebo controlled study with Paxil CR (paroxetine hydrochloride controlled-release tablets), which is thought as paroxetine with less side-effects. The main purpose of this study is to determine the effects of Paxil CR on memory deficits measured with neuropsychological testing, hippocampal volume measured with a magnetic resonance imaging (MRI), medial prefrontal lobe cortical function estimated with PET, and cortisol response (reflecting the intensity of stress) in men and women with PTSD. We plan to recruit 40 subjects. After completing physical examination and evaluating neuropsychiatric history, patients will undergo an initial group of tests which includes memory testing, MRI and PET brain scan, and measurement of cortisol in their saliva. Afterwards, half will receive Paxil CR 12.5 to 62.5 mg and half will receive a placebo (sugar pill) in the beginning of the first 12 weeks as "Double Blind Phase". After 12 weeks, they will be administered memory tests, PET and MRI scan for the post-treatment phase. After this period, Paxil CR will be offered to the placebo group and followed for an additional 12 weeks. They will have final memory tests, and a MRI scan. We hypothesize that Paxil CR exerts its efficacy by acting on abnormal neural circuits, including hippocampus and prefrontal cortex, in PTSD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Posttraumatic Stress Disorder (PTSD)
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic

Clinical Trial Details

NCT number	NCT00672776
Study type	Interventional
Source	Emory University
Contact
Status	Completed
Phase	Phase 4
Start date	May 2003
Completion date	September 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01443182` - Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma	N/A
Completed	`NCT01507948` - Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)	N/A
Completed	`NCT02911285` - NAC for Treating Comorbid PTSD and SUD	Phase 2
Recruiting	`NCT02234076` - A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma	N/A
Completed	`NCT01729026` - A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)	Early Phase 1
Completed	`NCT01406834` - Treatment for the Mental Health Impact of Killing in War	N/A
Completed	`NCT01446146` - Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice	N/A
Completed	`NCT01464892` - Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma	N/A
Active, not recruiting	`NCT03283163` - Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD	N/A
Completed	`NCT02442843` - Non Invasive Brain Stimulation for PTSD	Early Phase 1
Completed	`NCT01888653` - Attention-Bias Modification Treatment for PTSD	N/A
Completed	`NCT01474057` - DElivery of Self Training and Education for Stressful Situations-Primary Care Version	Phase 2
Completed	`NCT03641924` - Cognition and Psychotherapy in PTSD
Completed	`NCT02397889` - Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)	Phase 2/Phase 3
Completed	`NCT02322047` - Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders	Phase 2
Completed	`NCT00320138` - Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel	Phase 1
Recruiting	`NCT03833453` - Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD	N/A
Completed	`NCT03833531` - Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD	N/A
Completed	`NCT03529435` - Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD	N/A
Completed	`NCT01492348` - Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms